The Biden administration has halted a $125 million research program that aimed to collect and isolate thousands of exotic pathogens amid concerns from lawmakers and scientists that the research could trigger an accidental outbreak, The Washington Post reported Sept. 7.
Read the full post on Becker's Hospital Review - Healthcare News
